Historic Current Assets for Nuvation Bio (NUVB) over the last 4 years, with Jun 2025 value amounting to $623.2 million.
- Nuvation Bio's Current Assets rose 6.14% to $623.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $623.2 million, marking a year-over-year increase of 6.14%. This contributed to the annual value of $526.3 million for FY2024, which is 14.63% down from last year.
- Nuvation Bio's Current Assets amounted to $623.2 million in Q2 2025, which was up 31.05% from $475.6 million recorded in Q1 2025.
- In the past 5 years, Nuvation Bio's Current Assets ranged from a high of $830.9 million in Q1 2021 and a low of $475.6 million during Q1 2025.
- In the last 3 years, Nuvation Bio's Current Assets had a median value of $615.6 million in 2024 and averaged $596.8 million.
- As far as peak fluctuations go, Nuvation Bio's Current Assets surged by 24,062,522.08% in 2021, and later declined by 21.79% in 2025.
- Quarterly analysis of 5 years shows Nuvation Bio's Current Assets stood at $796.6 million in 2021, then declined by 14.46% to $681.4 million in 2022, then decreased by 8.22% to $625.3 million in 2023, then fell by 9.65% to $565.0 million in 2024, then grew by 6.14% to $623.2 million in 2025.
- Its Current Assets was $623.2 million in Q2 2025, compared to $475.6 million in Q1 2025 and $565.0 million in Q3 2024.
